United States Genitourinary Drugs Market Report 2017

February 2017 | 122 pages | ID: U3E2FD0A5D1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Genitourinary Drugs

Revenue, means the sales value of Genitourinary Drugs

This report studies sales (consumption) of Genitourinary Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Astellas
• Pfizer
• GlaxoSmithKline
• Eli Lilly
• Bayer AG
• Merck
• Abbott Laboratories
• Bristol-Myers Squibb
• Genentech
• Roche
• Amgen
• Botex

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Sex Hormones
• Urologicals
• Genitourinary Anti-Infectives
• Gynaecologicals

Split by applications, this report focuses on sales, market share and growth rate of Genitourinary Drugs in each application, can be divided into

• Genitourinary Cancer
• Bladder Cancer
• Cervical Cancer
• Kidney/Renal Cancer
• Ovarian Cancer
• Prostate Cancer

Contents

United States Genitourinary Drugs Market Report 2017

1 GENITOURINARY DRUGS OVERVIEW

1.1 Product Overview and Scope of Genitourinary Drugs
1.2 Classification of Genitourinary Drugs
  1.2.1 Sex Hormones
  1.2.2 Urologicals
  1.2.3 Genitourinary Anti-Infectives
  1.2.4 Gynaecologicals
1.3 Application of Genitourinary Drugs
  1.3.1 Genitourinary Cancer
  1.3.2 Bladder Cancer
  1.3.3 Cervical Cancer
  1.3.4 Kidney/Renal Cancer
  1.3.5 Ovarian Cancer
  1.3.6 Prostate Cancer
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Genitourinary Drugs (2012-2022)
  1.4.1 United States Genitourinary Drugs Sales and Growth Rate (2012-2022)
  1.4.2 United States Genitourinary Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES GENITOURINARY DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Genitourinary Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Genitourinary Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Genitourinary Drugs Average Price by Manufactures (2015 and 2016)
2.4 Genitourinary Drugs Market Competitive Situation and Trends
  2.4.1 Genitourinary Drugs Market Concentration Rate
  2.4.2 Genitourinary Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES GENITOURINARY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Genitourinary Drugs Sales and Market Share by States (2012-2017)
3.2 United States Genitourinary Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Genitourinary Drugs Price by States (2012-2017)

4 UNITED STATES GENITOURINARY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Genitourinary Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Genitourinary Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Genitourinary Drugs Price by Type (2012-2017)
4.4 United States Genitourinary Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES GENITOURINARY DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Genitourinary Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Genitourinary Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES GENITOURINARY DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Astellas
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Genitourinary Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.2 Genitourinary Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline
  6.3.2 Genitourinary Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Eli Lilly
  6.4.2 Genitourinary Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bayer AG
  6.5.2 Genitourinary Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Merck
  6.6.2 Genitourinary Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Abbott Laboratories
  6.7.2 Genitourinary Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb
  6.8.2 Genitourinary Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Genentech
  6.9.2 Genitourinary Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Roche
  6.10.2 Genitourinary Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Roche Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Amgen
6.12 Botex

7 GENITOURINARY DRUGS MANUFACTURING COST ANALYSIS

7.1 Genitourinary Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Genitourinary Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Genitourinary Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GENITOURINARY DRUGS MARKET FORECAST (2017-2022)

11.1 United States Genitourinary Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Genitourinary Drugs Sales Forecast by Type (2017-2022)
11.3 United States Genitourinary Drugs Sales Forecast by Application (2017-2022)
11.4 Genitourinary Drugs Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Genitourinary Drugs
Table Classification of Genitourinary Drugs
Figure United States Sales Market Share of Genitourinary Drugs by Type in 2015
Figure Sex Hormones Picture
Figure Urologicals Picture
Figure Genitourinary Anti-Infectives Picture
Figure Gynaecologicals Picture
Table Application of Genitourinary Drugs
Figure United States Sales Market Share of Genitourinary Drugs by Application in 2015
Figure Genitourinary Cancer Examples
Figure Bladder Cancer Examples
Figure Cervical Cancer Examples
Figure Kidney/Renal Cancer Examples
Figure Ovarian Cancer Examples
Figure Prostate Cancer Examples
Figure United States Genitourinary Drugs Sales and Growth Rate (2012-2022)
Figure United States Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Table United States Genitourinary Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Genitourinary Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Genitourinary Drugs Sales Share by Manufacturers
Figure 2016 Genitourinary Drugs Sales Share by Manufacturers
Table United States Genitourinary Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Genitourinary Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Genitourinary Drugs Revenue Share by Manufacturers
Table 2016 United States Genitourinary Drugs Revenue Share by Manufacturers
Table United States Market Genitourinary Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Genitourinary Drugs Average Price of Key Manufacturers in 2015
Figure Genitourinary Drugs Market Share of Top 3 Manufacturers
Figure Genitourinary Drugs Market Share of Top 5 Manufacturers
Table United States Genitourinary Drugs Sales by States (2012-2017)
Table United States Genitourinary Drugs Sales Share by States (2012-2017)
Figure United States Genitourinary Drugs Sales Market Share by States in 2015
Table United States Genitourinary Drugs Revenue and Market Share by States (2012-2017)
Table United States Genitourinary Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Genitourinary Drugs by States (2012-2017)
Table United States Genitourinary Drugs Price by States (2012-2017)
Table United States Genitourinary Drugs Sales by Type (2012-2017)
Table United States Genitourinary Drugs Sales Share by Type (2012-2017)
Figure United States Genitourinary Drugs Sales Market Share by Type in 2015
Table United States Genitourinary Drugs Revenue and Market Share by Type (2012-2017)
Table United States Genitourinary Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Genitourinary Drugs by Type (2012-2017)
Table United States Genitourinary Drugs Price by Type (2012-2017)
Figure United States Genitourinary Drugs Sales Growth Rate by Type (2012-2017)
Table United States Genitourinary Drugs Sales by Application (2012-2017)
Table United States Genitourinary Drugs Sales Market Share by Application (2012-2017)
Figure United States Genitourinary Drugs Sales Market Share by Application in 2015
Table United States Genitourinary Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Genitourinary Drugs Sales Growth Rate by Application (2012-2017)
Table Astellas Basic Information List
Table Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Genitourinary Drugs Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Genitourinary Drugs Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Genitourinary Drugs Sales Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Genitourinary Drugs Sales Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Genitourinary Drugs Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Genitourinary Drugs Sales Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Genitourinary Drugs Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Genitourinary Drugs Sales Market Share (2012-2017)
Table Genentech Basic Information List
Table Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Genentech Genitourinary Drugs Sales Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Genitourinary Drugs Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Botex Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Genitourinary Drugs
Figure Manufacturing Process Analysis of Genitourinary Drugs
Figure Genitourinary Drugs Industrial Chain Analysis
Table Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015
Table Major Buyers of Genitourinary Drugs
Table Distributors/Traders List
Figure United States Genitourinary Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Genitourinary Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Genitourinary Drugs Production Forecast by Type (2017-2022)
Table United States Genitourinary Drugs Consumption Forecast by Application (2017-2022)
Table United States Genitourinary Drugs Sales Forecast by States (2017-2022)
Table United States Genitourinary Drugs Sales Share Forecast by States (2017-2022)